187 related articles for article (PubMed ID: 36444392)
41. [Phenotypic and genetic features in neurofibromatosis type 1 in children].
Duat Rodríguez A; Martos Moreno GÁ; Martín Santo-Domingo Y; Hernández Martín A; Espejo-Saavedra Roca JM; Ruiz-Falcó Rojas ML; Argente J
An Pediatr (Barc); 2015 Sep; 83(3):173-82. PubMed ID: 25541118
[TBL] [Abstract][Full Text] [Related]
42. Knowledge and Self-Esteem of Individuals with Neurofibromatosis Type 1 (NF1).
Rosnau K; Hashmi SS; Northrup H; Slopis J; Noblin S; Ashfaq M
J Genet Couns; 2017 Jun; 26(3):620-627. PubMed ID: 27815662
[TBL] [Abstract][Full Text] [Related]
43. Quality of life in patients with neurofibromatosis type 1 and 2 in Canada.
Hamoy-Jimenez G; Kim R; Suppiah S; Zadeh G; Bril V; Barnett C
Neurooncol Adv; 2020 Jul; 2(Suppl 1):i141-i149. PubMed ID: 32642740
[TBL] [Abstract][Full Text] [Related]
44. [Expert consensus on diagnosis and management of neurofibromatosis type 1 (2021 edition)].
National Multi-Center Treatment Collaboration Group For Neurofibromatosis Type ; National Multi-Center Research Platform For Plastic And Reconstructive Surgery
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2021 Nov; 35(11):1384-1395. PubMed ID: 34779163
[TBL] [Abstract][Full Text] [Related]
45. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
[TBL] [Abstract][Full Text] [Related]
46. Appearance concerns among women with neurofibromatosis: examining sexual/bodily and social self-consciousness.
Smith KB; Wang DL; Plotkin SR; Park ER
Psychooncology; 2013 Dec; 22(12):2711-9. PubMed ID: 23873824
[TBL] [Abstract][Full Text] [Related]
47. Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1.
Corsello G; Antona V; Serra G; Zara F; Giambrone C; Lagalla L; Piccione M; Piro E
Ital J Pediatr; 2018 Apr; 44(1):45. PubMed ID: 29618358
[TBL] [Abstract][Full Text] [Related]
48. Neurofibromatosis Type 1: Review of Cutaneous and Subcutaneous Tumor Treatment on Quality of Life.
Taylor LA; Lewis VL
Plast Reconstr Surg Glob Open; 2019 Jan; 7(1):e1982. PubMed ID: 30859021
[TBL] [Abstract][Full Text] [Related]
49. Impact of neurofibromatosis type 1 in an adult community population.
Gregory TA; Molina PSB; Phillips GD; Henson JW
Neurooncol Pract; 2022 May; 9(3):229-235. PubMed ID: 35601964
[TBL] [Abstract][Full Text] [Related]
50. The psychological impact and experience of breast cancer screening in young women with an increased risk of breast cancer due to neurofibromatosis type 1.
Crook A; Kwa R; Ephraums S; Wilding M; Thiyagarajan L; Fleming J; Moore K; Berman Y
Fam Cancer; 2022 Apr; 21(2):241-253. PubMed ID: 33963463
[TBL] [Abstract][Full Text] [Related]
51. Quality of life and psychological adjustment in children and adolescents with neurofibromatosis type 1.
Graf A; Landolt MA; Mori AC; Boltshauser E
J Pediatr; 2006 Sep; 149(3):348-53. PubMed ID: 16939745
[TBL] [Abstract][Full Text] [Related]
52. Novel association of neurofibromatosis type 1-causing mutations in families with neurofibromatosis-Noonan syndrome.
Ekvall S; Sjörs K; Jonzon A; Vihinen M; Annerén G; Bondeson ML
Am J Med Genet A; 2014 Mar; 164A(3):579-87. PubMed ID: 24357598
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic difficulties and possibilities of NF1-like syndromes in childhood.
Pinti E; Nemeth K; Staub K; Lengyel A; Fekete G; Haltrich I
BMC Pediatr; 2021 Jul; 21(1):331. PubMed ID: 34325699
[TBL] [Abstract][Full Text] [Related]
54. Genetic basis of neurofibromatosis type 1 and related conditions, including mosaicism.
Legius E; Brems H
Childs Nerv Syst; 2020 Oct; 36(10):2285-2295. PubMed ID: 32601904
[TBL] [Abstract][Full Text] [Related]
55. Quality of Life in Adults with Neurofibromatosis 1 in Brazil.
Bicudo NP; de Menezes Neto BF; da Silva de Avó LR; Germano CM; Melo DG
J Genet Couns; 2016 Oct; 25(5):1063-74. PubMed ID: 26944915
[TBL] [Abstract][Full Text] [Related]
56. Assessment of pain and itch behavior in a mouse model of neurofibromatosis type 1.
O'Brien DE; Brenner DS; Gutmann DH; Gereau RW
J Pain; 2013 Jun; 14(6):628-37. PubMed ID: 23578956
[TBL] [Abstract][Full Text] [Related]
57. Quality of life among children and adolescents with neurofibromatosis 1: a systematic review of the literature.
Vranceanu AM; Merker VL; Park ER; Plotkin SR
J Neurooncol; 2015 Apr; 122(2):219-28. PubMed ID: 25663248
[TBL] [Abstract][Full Text] [Related]
58. Neurofibromatosis type 1.
Boyd KP; Korf BR; Theos A
J Am Acad Dermatol; 2009 Jul; 61(1):1-14; quiz 15-6. PubMed ID: 19539839
[TBL] [Abstract][Full Text] [Related]
59. Associations of clinical features in neurofibromatosis 1 (NF1).
Szudek J; Birch P; Riccardi VM; Evans DG; Friedman JM
Genet Epidemiol; 2000 Dec; 19(4):429-39. PubMed ID: 11108651
[TBL] [Abstract][Full Text] [Related]
60. Sexual Self-Esteem and Psychological Burden of Adults With Neurofibromatosis Type 1.
Leidger A; Vosschulte M; Nieder TO; Mautner VF
Front Psychol; 2022; 13():883019. PubMed ID: 35756263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
